Delivery Order SPE2DB22D2206-SPE2DB23FKM13
Award Date 9/21/23
Potential Completion Date 9/22/23
Potential Value $15
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $1,470 delivery order to Amerisourcebergen Drug Corporation for brimonidine 0.2% eye drops. As the prime contractor, Amerisourcebergen will supply 5mL bottles of the ophthalmic solution to support DLA programs. Performance will occur at Amerisourcebergen's facility in Conshohocken, Pennsylvania over a one-day period in late September 2023. The firm fixed price contract utilizes no set-aside designations and is issued against an existing DLA-wide supply...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at fifty-nine thousand four hundred forty-eight dollars to Amerisourcebergen Drug Corporation for brimonidine 0.2% eye drops. As the prime contractor, Amerisourcebergen will deliver five milliliter bottles of the eye drops to a location in Conshohocken, Pennsylvania by August 31, 2023 to support Defense Logistics Agency programs. Amerisourcebergen Corporation is the parent company of Amerisourcebergen Drug Corporation,...
- The Defense Logistics Agency awarded a $69,120 firm fixed price delivery order to Amerisourcebergen Drug Corporation for brimonidine 0.2% eye drops. As the prime contractor, Amerisourcebergen Drug Corporation will deliver 15 milliliters of the eye drops to a location in Conshohocken, Pennsylvania by August 25, 2023 to fulfill requirements under the contract. The Defense Logistics Agency is the Department of Defense's combat logistics support agency, responsible for worldwide logistics support in...
- <p>This delivery order for $17 of brimonidine 0.2% eye drops was awarded by the Defense Logistics Agency to Amerisourcebergen Drug Corp, located in Conshohocken, Pennsylvania. The order is for delivery of the specified pharmaceutical product by October 12, 2023 under a firm fixed price contract. No set-aside provisions were applied to this award to supply eye drops in support of the Defense Logistics Agency's medical logistics responsibilities.</p>
- The Defense Logistics Agency Troop Support Medical awarded a $20,580 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 5ml bottles of 0.2% brimonidine eye drops. The place of performance is Amerisourcebergen's facility in Conshohocken, Pennsylvania. The period of performance is August 24-25, 2023. No subcontractors or set aside designations were identified. The Defense Logistics Agency manages the global supply chain for the United States Department of Defense,...
- Defense Logistics Agency awarded a $27 firm fixed price delivery order contract to Amerisourcebergen Drug Corp for the purchase of brimonidine 0.2% eye drop medication. The contract has a period of performance through September 25, 2023. Amerisourcebergen Drug Corp will deliver the requested pharmaceutical product from its facility located in Conshohocken, Pennsylvania to support Defense Logistics Agency requirements. No set-aside provisions were applied to this award made under an existing...
- The Defense Logistics Agency awarded a $108,810 delivery order to Amerisourcebergen Drug Corporation for 4561680427 BETIMOL 0.5% eye drops. The firm fixed price order is for 5mL of the eye drops and will be fulfilled by Amerisourcebergen from its facility in Conshohocken, Pennsylvania by August 3, 2023. As a major provider of medical supplies and pharmaceuticals, Amerisourcebergen routinely supports the Defense Logistics Agency's mission to provide materials to all branches of the United...
- The Defense Logistics Agency awarded a $2,773.45 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4561935300 BRIMONIDINE-TIMOLOL 0.2%-0.5% 10ML. The place of performance will be Amerisourcebergen's Conshohocken, Pennsylvania facility. The single day order is for the branded ophthalmic solution and runs from August 24 through August 25, 2023. As a top pharmaceutical supplier, Amerisourcebergen will deliver the requested medications to the DLA, the Department of...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $1,745.53 firm fixed-price delivery order is for the supply of Brimonidine-Timolol 0.2%-0.5% eye drops in 10 mL bottles. The contract has an ultimate completion date of October 22, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at approximately $2,045 to Amerisourcebergen Drug Corporation for brimonidine tartrate 0.15% ophthalmic solution. The place of performance will be Amerisourcebergen's facility in Conshohocken, Pennsylvania. The single day order is scheduled to be completed by August 30, 2023. Amerisourcebergen Corporation is the parent company of Amerisourcebergen Drug Corporation, which will fulfill the order without the use of...
- SPE2DB22D2206Indefinite Delivery Contract
- SPE2DB22D2206-SPE2DB23FKM13Delivery Order
The Defense Logistics Agency awarded a $14,900 firm fixed price delivery order to Amerisourcebergen Drug Corporation for Brimomidine 0.2% eye drops. Under this contract, Amerisourcebergen will deliver 5mL bottles of the eye drops to a location in Conshohocken, Pennsylvania by September 22, 2023. As a major provider of medical supplies and pharmaceuticals, Amerisourcebergen routinely supports the Defense Logistics Agency's mission to provide critical resources to military treatment facilities around the world. No subcontractors or set aside designations were identified for this short-term delivery of an established pharmaceutical product in support of the Agency's healthcare requirements.
Generated 12/21/23, 10:44 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $15 | 9/21/23 |